Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: Liver Transpl. 2016 Jan;22(1):24–33. doi: 10.1002/lt.24366

Figure 2.

Figure 2

Relative Risk of SVR12 (SOF+SMV+RBV reference). (Excludes non-virological failures.)

Relative risks are Mantel-Haenszel estimates stratified on previous treatment (experienced v. naive). Previous treatment is a predictor of regimen choice (SOF+SMV v. SOF+SMV+RBV) among patients which completed treatment or discontinued due to virological reasons. (Relative risk estimates for Tx experienced and Tx Naive are not stratified.)